Your browser is no longer supported. Please, upgrade your browser.
Settings
QDEL Quidel Corporation daily Stock Chart
QDEL [NASD]
Quidel Corporation
Index- P/E152.85 EPS (ttm)0.42 Insider Own1.40% Shs Outstand38.66M Perf Week-0.27%
Market Cap2.46B Forward P/E21.73 EPS next Y2.93 Insider Trans-41.63% Shs Float34.07M Perf Month-13.14%
Income20.30M PEG3.09 EPS next Q0.48 Inst Own90.80% Short Float6.96% Perf Quarter-10.16%
Sales438.10M P/S5.62 EPS this Y42.70% Inst Trans0.45% Short Ratio8.74 Perf Half Y12.81%
Book/sh9.73 P/B6.55 EPS next Y3.82% ROA2.70% Target Price79.80 Perf Year48.72%
Cash/sh1.00 P/C63.67 EPS next 5Y49.50% ROE7.10% 52W Range33.01 - 77.63 Perf YTD47.04%
Dividend- P/FCF36.67 EPS past 5Y-29.50% ROI1.50% 52W High-17.89% Beta1.10
Dividend %- Quick Ratio0.70 Sales past 5Y12.30% Gross Margin56.90% 52W Low93.09% ATR2.15
Employees1193 Current Ratio1.10 Sales Q/Q169.50% Oper. Margin10.50% RSI (14)40.29 Volatility3.02% 3.43%
OptionableYes Debt/Eq0.36 EPS Q/Q77.10% Profit Margin4.60% Rel Volume0.85 Prev Close63.70
ShortableYes LT Debt/Eq0.22 EarningsNov 06 AMC Payout0.00% Avg Volume271.48K Price63.74
Recom1.90 SMA20-2.32% SMA50-7.70% SMA2007.71% Volume230,371 Change0.06%
Mar-08-18Upgrade Raymond James Outperform → Strong Buy
Jan-22-18Reiterated Barclays Overweight $50 → $60
Jan-04-18Upgrade CL King Neutral → Buy
Sep-19-17Upgrade Piper Jaffray Neutral → Overweight
Jul-18-17Upgrade William Blair Mkt Perform → Outperform
Jul-18-17Upgrade Canaccord Genuity Hold → Buy $25 → $42
Apr-25-17Reiterated Canaccord Genuity Hold $24 → $24.50
Feb-17-17Initiated CL King Neutral
Dec-16-16Downgrade Piper Jaffray Overweight → Neutral
Jun-13-16Upgrade Raymond James Mkt Perform → Outperform
Feb-18-16Reiterated Barclays Overweight $28 → $22
Feb-09-16Downgrade Canaccord Genuity Buy → Hold $22 → $18
Jan-08-16Reiterated Canaccord Genuity Buy $25 → $22
Dec-14-15Downgrade Raymond James Outperform → Mkt Perform
Sep-02-15Initiated Barclays Overweight $28
Jul-31-13Reiterated Canaccord Genuity Buy $30 → $35
Mar-03-11Downgrade Wedbush Outperform → Neutral $14 → $13
Nov-16-10Initiated Canaccord Genuity Buy $18
May-27-10Upgrade Wedbush Neutral → Outperform $15
Apr-07-10Initiated Wedbush Neutral $15
Oct-09-18 08:35AM  Research Report Identifies Keysight Technologies, Quidel, LKQ, Louisiana-Pacific, Air Transport Services Group, and Del Frisco's Restaurant Group with Renewed Outlook Fundamental Analysis, Calculating Forward Movement GlobeNewswire
Sep-24-18 11:43AM  Is Quidel Corporations (NASDAQ:QDEL) Liquidity Good Enough? Simply Wall St.
08:45AM  Are Options Traders Betting on a Big Move in Quidel (QDEL) Stock? Zacks
Sep-20-18 09:31AM  3 Top Stocks From the Booming US Medical Products Industry Zacks
Sep-18-18 06:41PM  Medical - Products Stock Outlook: Short-Term Pain Inevitable Zacks
Sep-05-18 10:21AM  Agios (AGIO) Assigns Ex-Celgene Executive to CEO Position Zacks
Aug-31-18 08:29AM  The Daily Biotech Pulse: FDA Blessings for Merck's HIV Drug Combo, Veracyte's Test Gets Medicare Coverage Benzinga
Aug-30-18 06:40PM  Quidel Receives FDA Clearance, CLIA Waiver for Its Point-of-Care Sofia® 2 Lyme Fluorescent Immunoassay for Use with Sofia® 2 Instrument from Finger-Stick Whole Blood Specimens Business Wire
Aug-20-18 05:45PM  Edited Transcript of QDEL earnings conference call or presentation 7-Aug-18 9:00pm GMT Thomson Reuters StreetEvents
Aug-16-18 09:00AM  Implied Volatility Surging for Quidel (QDEL) Stock Options Zacks
Aug-07-18 08:05PM  Quidel (QDEL) Surpasses Q2 Earnings and Revenue Estimates Zacks
06:59PM  Quidel: 2Q Earnings Snapshot Associated Press
04:10PM  Quidel Reports Second Quarter 2018 Financial Results Business Wire
Jul-31-18 08:00AM  New Research Coverage Highlights Federated Investors, SailPoint Technologies, Quidel, L3 Technologies, Pentair plc, and Veeva Consolidated Revenues, Company Growth, and Expectations for 2018 GlobeNewswire
Jul-17-18 04:10PM  Quidel to Hold Second Quarter 2018 Financial Results Conference Call on August 7, 2018 Business Wire
Jul-16-18 01:00PM  Quidel Receives FDA Clearance for Solana® Bordetella Complete® Molecular Diagnostic Assay for the Detection of Pertussis (Whooping Cough), Parapertussis Infections Business Wire
Jun-22-18 02:17PM  Is Quidel Corporation (NASDAQ:QDEL) Worth US$069.58 Based On Intrinsic Value? Simply Wall St.
Jun-13-18 08:36AM  Implied Volatility Surging for Quidel (QDEL) Stock Options Zacks
Jun-05-18 04:10PM  Quidel to Present at William Blair 38th Annual Growth Stock Conference Business Wire
May-31-18 10:15PM  Quidel Announces Private Exchange Transactions Business Wire
May-16-18 10:10AM  Is SPDR S&P Health Care Equipment ETF (XHE) a Hot ETF Right Now? Zacks
May-15-18 05:00PM  Quidel to Present at UBS Global Healthcare Conference Business Wire
May-11-18 01:56AM  Edited Transcript of QDEL earnings conference call or presentation 8-May-18 9:00pm GMT Thomson Reuters StreetEvents
May-08-18 06:49PM  Quidel: 1Q Earnings Snapshot Associated Press
04:10PM  Quidel Reports First Quarter 2018 Financial Results Business Wire
Apr-23-18 04:10PM  Quidel to Hold First Quarter 2018 Financial Results Conference Call on May 8, 2018 Business Wire
Apr-18-18 07:40AM  New Research Coverage Highlights Quidel, Eros International, Hennessy Capital Acquisition Corp. II, United Dominion Realty Trust, Fidus Investment, and Kadant Consolidated Revenues, Company Growth, and Expectations for 2018 GlobeNewswire
Apr-06-18 08:31AM  Is the Options Market Predicting a Spike in Quidel (QDEL) Stock? Zacks
Mar-29-18 08:15AM  New Research Coverage Highlights Digital Realty Trust, United Dominion Realty Trust, Quidel, Brandywine Realty Trust, Beneficial, and Coca-Cola Bottling Co. Consolidated Consolidated Revenues, Company Growth, and Expectations for 2018 GlobeNewswire
Mar-27-18 05:00PM  Quidel to Host 2018 Analyst and Investor Day in Chicago Business Wire
Mar-15-18 08:51AM  Implied Volatility Surging for Quidel (QDEL) Stock Options Zacks
Mar-08-18 07:00PM  Quidel Announces Private Exchange Transactions Business Wire
01:06PM  Near-Term Catalysts, Long-Term Opportunities Make Quidel A Strong Buy, Says Raymond James Benzinga
Mar-06-18 08:26AM  Benzinga Pro's 5 Stocks To Watch Today Benzinga
Mar-05-18 04:10PM  Quidel Receives FDA Clearance for Its Point-of-Care Sofia® Lyme Fluorescent Immunoassay for Use with Sofia® 2 Instrument Business Wire
Feb-26-18 05:30PM  Quidel to Present at Upcoming Conferences Business Wire
Feb-22-18 02:26PM  Edited Transcript of QDEL earnings conference call or presentation 21-Feb-18 10:00pm GMT Thomson Reuters StreetEvents -5.80%
Feb-21-18 07:19PM  Quidel reports 4Q loss Associated Press
04:10PM  Quidel Reports Fourth Quarter and Full Year 2017 Financial Results Business Wire
Feb-13-18 06:45PM  Quidel Receives 510(k) Clearance for QuickVue® Influenza A+B Test, Assay Meets FDAs Class II RIDT Requirements Business Wire
Feb-12-18 08:33AM  Options Traders Expect Huge Moves in Quidel (QDEL) Stock Zacks
Feb-07-18 06:16PM  Quidel to Hold Fourth Quarter and Full Year 2017 Financial Results Conference Call on February 21, 2018 Business Wire
Jan-26-18 07:55AM  Report: Developing Opportunities within Quidel, Earthstone Energy, Potbelly, Chemed, Great Southern, and Intel Future Expectations, Projections Moving into 2018 GlobeNewswire
Jan-19-18 08:30AM  Implied Volatility Surging for Quidel (QDEL) Stock Options Zacks
Jan-05-18 02:45PM  Quidel Completes Sale Leaseback of Summers Ridge Property for $148.65 Million Business Wire
Dec-21-17 06:50PM  Quidel Receives FDA Clearance and CLIA Waiver for Its Point-of-Care Sofia® 2 Instrument for Use with Sofia Strep A+ Assay Business Wire
06:45PM  Quidel Receives FDA Clearance for Its New Solana® Molecular Assay for the Detection of Group B Streptococcal Infections Business Wire
06:00PM  Quidel to Present at 36th Annual J.P. Morgan Healthcare Conference Business Wire
11:45AM  ETFs with exposure to Quidel Corp. : December 21, 2017 Capital Cube
Dec-19-17 05:37PM  Quidel Files Form 8-K/A, Reports Historical and Pro Forma Financial Information for Acquired Triage Assets and Combined Quidel and Triage Businesses Business Wire
Dec-13-17 07:00PM  Quidel Announces Timing of Filing of Form 8-K/A To Report Historical and Pro Forma Financial Information for Acquired Triage Assets and Combined Quidel and Triage Businesses Business Wire
Dec-11-17 07:24AM  Quidel Corp. breached its 50 day moving average in a Bullish Manner : QDEL-US : December 11, 2017 Capital Cube
Nov-28-17 01:05PM  ETFs with exposure to Quidel Corp. : November 28, 2017 Capital Cube
Nov-27-17 04:13PM  Why Quidel Corporation Is Sinking Motley Fool -8.97%
12:40PM  Quidel Confident in Legal Strength and Validity of Supply Agreement with Beckman Coulter to Sell BNP Assay Assets Business Wire
Nov-15-17 04:05PM  Quidel to Present at the 29th Annual Piper Jaffray Healthcare Conference Business Wire
Nov-08-17 06:29PM  ETFs with exposure to Quidel Corp. : November 8, 2017 Capital Cube
Nov-07-17 08:06AM  Quidel Corp. :QDEL-US: Earnings Analysis: Q3, 2017 By the Numbers : November 7, 2017 Capital Cube
Nov-06-17 01:16PM  Quidel Corp. Value Analysis (NASDAQ:QDEL) : November 6, 2017 Capital Cube
Nov-03-17 08:35AM  Quidel Corp. breached its 50 day moving average in a Bearish Manner : QDEL-US : November 3, 2017 Capital Cube
Nov-02-17 11:50AM  Edited Transcript of QDEL earnings conference call or presentation 1-Nov-17 9:00pm GMT Thomson Reuters StreetEvents
Nov-01-17 06:39PM  Quidel reports 3Q loss Associated Press
04:10PM  Quidel Reports Third Quarter 2017 Financial Results Business Wire
Oct-23-17 08:30AM  Quidel Receives FDA Clearance for Its Point-of-Care Sofia® Lyme FIA Business Wire
Oct-17-17 08:30AM  Quidel Receives FDA Clearance for Its Solana® RSV + hMPV Assay Business Wire
Oct-16-17 09:21AM  Top Ranked Momentum Stocks to Buy for October 16th Zacks
Oct-13-17 04:30PM  Quidel to Hold Third Quarter 2017 Financial Results Conference Call on November 1, 2017 Business Wire
09:27AM  5 MedTech Momentum Picks Investors Will Love Zacks
Oct-06-17 10:19AM  Quidel Announces Closing of Acquisition of Alere Triage® Assets Creating an Expanded Portfolio of Rapid Diagnostic Capabilities in Critical Care Settings Business Wire
Sep-28-17 02:00PM  Quidel Announces Early Termination of the Hart-Scott-Rodino Waiting Period for Its Pending Acquisition of Aleres Triage® B-type Naturietic Peptide (BNP) Assay Business Run on Beckman Coulter Analyzers Business Wire +5.48%
Sep-20-17 08:35AM  Quidel Corporation (QDEL) Jumps: Stock Rises 6.5% Zacks
Sep-19-17 12:23PM  Here's Why Quidel Corporation Stock Is Popping Today Motley Fool +6.45%
Sep-18-17 07:00AM  Quidel Announces Revised Agreement for Its Pending Acquisition of Aleres B-type Naturietic Peptide (BNP) Assay Business Run on Beckman Coulter Analyzers Business Wire +14.24%
Sep-08-17 09:00AM  Quidel to Participate in the CEO Series Conference Call Hosted by Canaccord Genuity Business Wire
Aug-15-17 04:54PM  ETFs with exposure to Quidel Corp. : August 15, 2017 Capital Cube
Aug-13-17 12:46PM  Edited Transcript of QDEL earnings conference call or presentation 24-Apr-17 9:00pm GMT Thomson Reuters StreetEvents
Aug-12-17 03:06AM  Edited Transcript of QDEL earnings conference call or presentation 26-Jul-17 9:00pm GMT Thomson Reuters StreetEvents
Aug-01-17 11:54AM  Quidel Corp. :QDEL-US: Earnings Analysis: Q2, 2017 By the Numbers : August 1, 2017 Capital Cube
Jul-31-17 04:10PM  Quidel to Present at the 37th Annual Canaccord Genuity Growth Conference Business Wire
Jul-27-17 01:06AM  Quidel reports 2Q loss Associated Press
Jul-26-17 04:10PM  Quidel Reports Second Quarter 2017 Financial Results Business Wire
Jul-19-17 03:56PM  Alere, St. Jude Deals in Focus as Abbott Releases Q2 Earnings TheStreet.com
07:00AM  Corporate News Blog - Quidel to Acquire Alere Triage(R) Assets Accesswire
Jul-18-17 05:21PM  Quidel Diversifies With Alere's Triage Assets TheStreet.com +9.50%
02:27PM  Abbott's Tarnished Deal Sparkles for Another Bloomberg
01:04PM  Here's Why Quidel Corporation Is Rising Today Motley Fool
08:20AM  Quidel (QDEL) Worth a Look: Stock Jumps 25.4% in Session Zacks
Jul-17-17 06:00AM  Quidel Announces Definitive Agreement to Acquire Alere Triage® Assets Business Wire +25.35%
Jul-14-17 04:05PM  Quidel to Hold Second Quarter 2017 Financial Results Conference Call on July 26, 2017 Business Wire
Jun-28-17 03:45PM  Quidel Receives FDA Clearance and CLIA Waiver for Its Point-of-Care Sofia® 2 Instrument for Use with Sofia Respiratory Syncytial Virus (RSV) Assay Business Wire
Jun-22-17 06:45PM  Quidels Sofia® 2 Point-of-Care Immunoassay Analyzer Receives Multiple Awards from Good Design Australia®s 2017 Good Design Awards® Business Wire
Jun-07-17 06:00PM  Quidel Receives the CE Mark for Its Thyretain® TBI Reporter BioAssay Business Wire
May-30-17 02:15PM  Quidel Receives FDA Clearance and CLIA Waiver for Its Point-of-Care Sofia® 2 Immunoassay Analyzer for Use with Sofia Influenza A+B Assay Business Wire
May-24-17 06:30PM  Quidel Receives PMDA Approval for Its Point-of-Care Sofia® Influenza A+B Assay Business Wire
May-18-17 01:58PM  ETFs with exposure to Quidel Corp. : May 18, 2017 Capital Cube
May-16-17 05:15PM  Quidel Completes Acquisition of InflammaDry(R) and AdenoPlus(R) Eye-Health Businesses Marketwired
May-11-17 02:30PM  Quidel Receives FDA Clearance for Its New Solana(R) Molecular Assay for the Detection of Clostridium difficile (C. difficile) Infections Marketwired
May-02-17 04:31PM  ETFs with exposure to Quidel Corp. : May 2, 2017 Capital Cube
May-01-17 05:30PM  Quidel to Present at the Bank of America Merrill Lynch 2017 Health Care Conference Marketwired
11:13AM  Quidel Corp. :QDEL-US: Earnings Analysis: Q1, 2017 By the Numbers : May 1, 2017 Capital Cube
Quidel Corporation develops, manufactures, and markets diagnostic testing solutions for applications in infectious diseases, cardiology, thyroid, women's and general health, eye health, gastrointestinal diseases, and toxicology. The company offers Sofia and Sofia 2 fluorescent immunoassay systems; QuickVue, a lateral flow immunoassay products; and InflammaDry and AdenoPlus products point-of-care products for the detection of infectious and inflammatory diseases and conditions of the eye. It also provides Triage MeterPro, a portable testing platform that enables physicians to promote enhanced health outcomes, as well as the detection of certain drugs of abuse; Triage BNP test for use on Beckman Coulter lab analyzers; and Triage TOX drug screen, which provides results for the determination of the presence of drug and/or the major metabolites in urine. In addition, the company offers traditional cell lines, specimen collection devices, media, and controls for use in laboratories that culture and test for various human viruses, including respiratory and herpes family viruses; and cell-based products comprising tubes, shell vials, and multi-well plates. Further, it provides biomarkers, which include clinical and research products for the assessment of osteoporosis and the evaluation of bone resorption/formation; and enzyme linked immunosorbent assays and reagents for the detection of activation products. Additionally, the company offers AmpliVue hand-held molecular diagnostic assay platform for the detection of the pathogen; Solana, an amplification and detection system; and Lyra molecular real-time polymerase chain reaction assays. The company markets its products through distributors and direct sales force for use in physician offices, hospitals, clinical laboratories, reference laboratories, leading universities, retail clinics, pharmacies, and wellness screening centers. Quidel Corporation was founded in 1979 and is headquartered in San Diego, California.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
BRYANT DOUGLAS CPresident & CEOSep 28Option Exercise12.3625,250312,090319,563Oct 01 08:10 PM
BRYANT DOUGLAS CPresident & CEOSep 28Sale65.1925,2501,646,048294,313Oct 01 08:10 PM
Russell Edward KeithS.V.P., N.A. Commercial OpsSep 11Option Exercise17.1113,000222,41021,887Sep 13 08:05 PM
Russell Edward KeithS.V.P., N.A. Commercial OpsSep 11Sale72.2913,000939,7328,887Sep 13 08:05 PM
BUECHLER KENNETH FDirectorAug 30Option Exercise11.965,00059,80053,519Sep 04 08:03 PM
BUECHLER KENNETH FDirectorAug 30Sale75.015,000375,03948,519Sep 04 08:03 PM
POLAN MARY LAKE PH DDirectorAug 28Sale70.802,358166,93815,179Aug 30 07:59 PM
POLAN MARY LAKE PH DDirectorAug 27Sale70.056,427450,18617,537Aug 27 08:16 PM
POLAN MARY LAKE PH DDirectorAug 24Sale70.025,689398,33023,964Aug 27 08:16 PM
POLAN MARY LAKE PH DDirectorAug 23Sale70.013,886272,04229,653Aug 27 08:16 PM
POLAN MARY LAKE PH DDirectorAug 20Option Exercise11.9616,002191,38433,539Aug 22 08:02 PM
Abney Michael Donald Jr.SVP - DistributionAug 17Option Exercise15.4017,596270,97826,153Aug 21 08:01 PM
Bujarski Robert JosephSVP, Bus Dev & Gen CounselAug 17Option Exercise20.1033,550674,23179,931Aug 21 08:02 PM
STEWARD RANDALL JChief Financial OfficerAug 17Option Exercise27.5738,1621,052,12669,952Aug 21 08:04 PM
Abney Michael Donald Jr.SVP - DistributionAug 17Sale70.4017,5961,238,8068,721Aug 21 08:01 PM
Bujarski Robert JosephSVP, Bus Dev & Gen CounselAug 17Sale70.1538,5502,704,24841,381Aug 21 08:02 PM
STEWARD RANDALL JChief Financial OfficerAug 17Sale70.1538,1622,677,07231,790Aug 21 08:04 PM
Brown Thomas DDirectorAug 15Option Exercise15.0815,600235,24869,558Aug 17 07:57 PM
Brown Thomas DDirectorAug 15Sale70.1215,6001,093,87253,958Aug 17 07:57 PM
SLACIK CHARLES PDirectorAug 10Sale68.281,00068,2847,820Aug 14 08:03 PM
BRYANT DOUGLAS CPresident & CEOJul 31Option Exercise12.3612,000148,320306,313Jul 31 08:03 PM
BRYANT DOUGLAS CPresident & CEOJul 31Sale67.3612,000808,320294,313Jul 31 08:03 PM
BRYANT DOUGLAS CPresident & CEOJul 30Option Exercise12.3612,000148,320306,313Jul 31 08:03 PM
BRYANT DOUGLAS CPresident & CEOJul 30Sale65.8412,000790,080294,313Jul 31 08:03 PM
BRYANT DOUGLAS CPresident & CEOJul 27Option Exercise12.3612,000148,320306,313Jul 31 08:03 PM
BRYANT DOUGLAS CPresident & CEOJul 27Sale67.5812,000810,984294,313Jul 31 08:03 PM
Russell Edward KeithS.V.P., N.A. Commercial OpsJul 12Option Exercise18.3210,000183,20018,887Jul 13 07:22 PM
Russell Edward KeithS.V.P., N.A. Commercial OpsJul 12Sale68.0910,000680,9388,887Jul 13 07:22 PM
BRYANT DOUGLAS CPresident & CEOJun 29Option Exercise12.3612,000148,320306,313Jun 29 07:55 PM
BRYANT DOUGLAS CPresident & CEOJun 29Sale66.5512,000798,600294,313Jun 29 07:55 PM
BRYANT DOUGLAS CPresident & CEOJun 28Option Exercise12.3612,000148,320306,313Jun 29 07:55 PM
BRYANT DOUGLAS CPresident & CEOJun 28Sale65.3212,000783,840294,313Jun 29 07:55 PM
BRYANT DOUGLAS CPresident & CEOJun 27Option Exercise12.3612,000148,320306,313Jun 29 07:55 PM
BRYANT DOUGLAS CPresident & CEOJun 27Sale66.2712,000795,204294,313Jun 29 07:55 PM
BORKAR RATAN SSVP, Intl Comm OperationsJun 12Option Exercise25.6423,185594,47436,319Jun 13 07:57 PM
Kroll WernerSVP, R&DJun 12Sale66.162,500165,39216,005Jun 13 08:00 PM
BORKAR RATAN SSVP, Intl Comm OperationsJun 12Sale65.0023,1851,507,02513,134Jun 13 07:57 PM
BORKAR RATAN SSVP, Intl Comm OperationsJun 11Option Exercise27.573,37092,91116,504Jun 13 07:57 PM
BORKAR RATAN SSVP, Intl Comm OperationsJun 11Sale65.003,370219,05013,134Jun 13 07:57 PM
BRYANT DOUGLAS CPresident & CEOMay 31Option Exercise12.3612,000148,320306,313May 31 08:05 PM
BRYANT DOUGLAS CPresident & CEOMay 31Sale62.7112,000752,496294,313May 31 08:05 PM
BRYANT DOUGLAS CPresident & CEOMay 30Option Exercise12.3612,000148,320306,313May 31 08:05 PM
BRYANT DOUGLAS CPresident & CEOMay 30Sale62.5712,000750,804294,313May 31 08:05 PM
BRYANT DOUGLAS CPresident & CEOMay 29Option Exercise12.3612,000148,320306,313May 31 08:05 PM
BRYANT DOUGLAS CPresident & CEOMay 29Sale60.9512,000731,400294,313May 31 08:05 PM
Brown Thomas DDirectorMay 25Option Exercise12.5730,451382,83384,409May 25 08:08 PM
Brown Thomas DDirectorMay 25Sale61.3430,4511,867,86453,958May 25 08:08 PM
WIDDER KENNETH JDirectorMay 17Option Exercise0.003,060010,655May 17 08:17 PM
SLACIK CHARLES PDirectorMay 17Option Exercise0.004,20308,820May 17 08:13 PM
POLAN MARY LAKE PH DDirectorMay 17Option Exercise0.003,315023,937May 17 08:10 PM
BUECHLER KENNETH FDirectorMay 17Option Exercise0.007,044048,519May 17 08:07 PM
Brown Thomas DDirectorMay 17Option Exercise0.003,823053,958May 17 08:05 PM
WIDDER KENNETH JDirectorMay 16Option Exercise0.002,01607,595May 17 08:17 PM
Strobeck MatthewDirectorMay 16Option Exercise0.0010803,638May 17 08:15 PM
SLACIK CHARLES PDirectorMay 16Option Exercise0.002,01604,617May 17 08:13 PM
POLAN MARY LAKE PH DDirectorMay 16Option Exercise0.002,016020,622May 17 08:10 PM
BUECHLER KENNETH FDirectorMay 16Option Exercise0.002,328041,475May 17 08:07 PM
Brown Thomas DDirectorMay 16Option Exercise0.002,016050,135May 17 08:05 PM
POLAN MARY LAKE PH DDirectorMay 06Option Exercise0.002,476018,606May 08 08:10 PM
Brown Thomas DDirectorMay 06Option Exercise0.003,094048,119May 08 08:09 PM
BRYANT DOUGLAS CPresident & CEOApr 30Option Exercise12.3612,000148,320306,313Apr 30 08:05 PM
BRYANT DOUGLAS CPresident & CEOApr 30Sale56.6412,000679,656294,313Apr 30 08:05 PM
BRYANT DOUGLAS CPresident & CEOApr 27Option Exercise12.3612,000148,320306,313Apr 30 08:05 PM
BRYANT DOUGLAS CPresident & CEOApr 27Sale56.0212,000672,204294,313Apr 30 08:05 PM
BRYANT DOUGLAS CPresident & CEOApr 26Option Exercise12.3612,000148,320306,313Apr 30 08:05 PM
BRYANT DOUGLAS CPresident & CEOApr 26Sale55.6112,000667,308294,313Apr 30 08:05 PM
BRYANT DOUGLAS CPresident & CEOMar 29Option Exercise12.3612,000148,320306,313Mar 29 08:04 PM
BRYANT DOUGLAS CPresident & CEOMar 29Sale52.0112,000624,120294,313Mar 29 08:04 PM
BRYANT DOUGLAS CPresident & CEOMar 28Option Exercise12.3612,000148,320306,313Mar 29 08:04 PM
BRYANT DOUGLAS CPresident & CEOMar 28Sale51.3712,000616,464294,313Mar 29 08:04 PM
BRYANT DOUGLAS CPresident & CEOMar 27Option Exercise12.3612,000148,320306,313Mar 29 08:04 PM
BRYANT DOUGLAS CPresident & CEOMar 27Sale51.5112,000618,156294,313Mar 29 08:04 PM
BRYANT DOUGLAS CPresident & CEOFeb 28Option Exercise12.3612,000148,320302,843Feb 28 08:27 PM
BRYANT DOUGLAS CPresident & CEOFeb 28Sale43.8512,000526,140290,843Feb 28 08:27 PM
BRYANT DOUGLAS CPresident & CEOFeb 27Option Exercise12.3612,000148,320302,843Feb 28 08:27 PM
BRYANT DOUGLAS CPresident & CEOFeb 27Sale44.4812,000533,772290,843Feb 28 08:27 PM
BRYANT DOUGLAS CPresident & CEOFeb 26Option Exercise12.3612,000148,320302,843Feb 28 08:27 PM
BRYANT DOUGLAS CPresident & CEOFeb 26Sale44.6312,000535,608290,843Feb 28 08:27 PM
BUECHLER KENNETH FDirectorFeb 15Option Exercise16.2512,154197,50339,147Feb 20 08:42 PM
BRYANT DOUGLAS CPresident & CEOJan 31Option Exercise12.3612,000148,320286,493Jan 31 08:03 PM
BRYANT DOUGLAS CPresident & CEOJan 31Sale46.0612,000552,720274,493Jan 31 08:03 PM
BRYANT DOUGLAS CPresident & CEOJan 30Option Exercise12.3612,000148,320286,493Jan 31 08:03 PM
BRYANT DOUGLAS CPresident & CEOJan 30Sale46.8212,000561,840274,493Jan 31 08:03 PM
BRYANT DOUGLAS CPresident & CEOJan 29Option Exercise12.3612,000148,320286,493Jan 31 08:03 PM
BRYANT DOUGLAS CPresident & CEOJan 29Sale47.9812,000575,760274,493Jan 31 08:03 PM
SCHULER JACK WDirectorJan 22Sale48.5012,000582,0313,414,053Jan 24 08:20 PM
SCHULER JACK WDirectorJan 05Sale47.024,000188,0803,426,053Jan 09 08:49 PM
BORKAR RATAN SSVP, Intl Comm OperationsJan 04Option Exercise22.219,590212,99417,232Jan 05 08:11 PM
POLAN MARY LAKE PH DDirectorJan 04Option Exercise16.2512,154197,50325,166Jan 05 08:13 PM
BORKAR RATAN SSVP, Intl Comm OperationsJan 04Sale45.489,590436,1537,642Jan 05 08:11 PM
BORKAR RATAN SSVP, Intl Comm OperationsJan 03Option Exercise17.8520,290362,11227,932Jan 05 08:11 PM
BORKAR RATAN SSVP, Intl Comm OperationsJan 03Sale45.0020,290913,0507,642Jan 05 08:11 PM
BRYANT DOUGLAS CPresident & CEODec 29Option Exercise12.3612,000148,320286,493Dec 29 07:29 PM
BRYANT DOUGLAS CPresident & CEODec 29Sale43.6912,000524,280274,493Dec 29 07:29 PM
BRYANT DOUGLAS CPresident & CEODec 28Option Exercise12.3612,000148,320286,493Dec 29 07:29 PM
BRYANT DOUGLAS CPresident & CEODec 28Sale44.1212,000529,440274,493Dec 29 07:29 PM
BRYANT DOUGLAS CPresident & CEODec 27Option Exercise12.3612,000148,320286,493Dec 29 07:29 PM
BRYANT DOUGLAS CPresident & CEODec 27Sale44.5012,000534,000274,493Dec 29 07:29 PM
SCHULER JACK WDirectorDec 21Sale46.0050023,0003,365,053Dec 22 08:19 PM
SCHULER JACK WDirectorDec 20Sale44.403,500155,4003,365,553Dec 22 08:19 PM